Sandoz Aims For $6bn Biosimilar Business By 2030

Sandoz Has A 22% Share Of Global Biosimilars Market At Present

Green Pin In Year 2030
Sandoz has ambitions to treble the size of its biosimilar business by 2030 • Source: Shutterstock

More from Biosimilars

More from Products